Cfara Injection
164,36$
128,20$
Cfara Injection serves as a purine nucleoside metabolic inhibitor, specifically designed to address acute lymphoblastic leukaemia (ALL) in pediatric patients aged 1 to 21 years. This targeted treatment option is utilized when other therapies have proven ineffective or have ceased to provide benefits. By disrupting the metabolism of purine nucleosides, Cfara Injection helps to inhibit the growth and proliferation of malignant white blood cells, thereby assisting in the management of this aggressive form of cancer. It is crucial for healthcare providers to monitor patients closely for potential side effects and to assess overall treatment response. Patients receiving Cfara Injection should be informed about the importance of adhering to follow-up appointments and lab tests to ensure optimal safety and effectiveness. As with any medication, a thorough discussion of risks and benefits with a healthcare professional is essential prior to initiation. With its focused approach, Cfara Injection represents a vital option in the ongoing fight against ALL, aiming to improve outcomes for young patients facing this challenging diagnosis.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Cfara injection is primarily indicated for the treatment of acute lymphoblastic leukaemia (ALL), a malignancy that predominantly impacts white blood cells. This form of cancer requires prompt and effective intervention to manage its progression. By targeting the cancerous cells, Cfara injection helps to improve patient outcomes. It plays a vital role in the overall treatment plan for individuals diagnosed with this condition.
• In the context of acute lymphoblastic leukaemia, Cfara injection assists in reducing the burden of disease by inhibiting the proliferation of abnormal cells. This action is crucial for restoring normal blood cell production and function. Patients receiving Cfara injection may experience a more manageable course of treatment, allowing for improved quality of life. Its use is often part of a comprehensive therapeutic approach tailored to the patient's needs.
• Healthcare providers may choose Cfara injection as part of combination therapy for patients with ALL, enhancing the overall effectiveness of the treatment regimen. This combination can lead to better disease control and increased chances of remission. Regular monitoring during treatment with Cfara injection is essential to assess its effectiveness. The goal is to provide patients with the best possible outcomes while navigating the challenges of this aggressive cancer.
• Cfara injection is administered in a clinical setting under the supervision of healthcare professionals, ensuring safety and efficacy. It is an essential component in the fight against acute lymphoblastic leukaemia, offering hope to patients and their families. The use of Cfara injection is informed by ongoing research and clinical guidelines, aiming to optimize therapeutic strategies. As part of the treatment plan, it supports the broader goal of achieving remission and improving survival rates.
Benefits
Blood cancer (Acute lymphocytic leukaemia): Blood cancer, also called leukaemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Cfara Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Cfara Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Stomach pain
• Vomiting
• Anxiety
• Fatigue
• Itching and Rashes
• Headache
Common Side Effects
• Constipation
• Irritability
• Drowsiness
• Pain in the back, arms, or legs
• Diarrhea
• Depression
• Lightheadedness
• Decreased urination
• Confusion
• Pale skin
How To Use
Cfara Injection is given intravenously under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Cfara Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Cfara Injection is safe for use in mild to moderate liver disease, no dose adjustment is necessary for these types of people. People suffering from severe liver disease do not use this Cfara Injection.
• Breastfeeding: It is not recommended to breastfeed while taking Benefits of Cfara Injection. Cfara Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Cfara Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Pregnancy: Use of Cfara Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Cfara Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Cfara Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.